Becton Dickinson & Co. (BD) has released its financial results for the fourth fiscal quarter ending September 30, 2026. This report is significant as it reflects the company’s performance in the surgical and medical instruments sector, a critical area in the healthcare industry.

On November 5, 2026, the company issued a press release detailing its financial outcomes, which included non-GAAP measures that differ from standard accounting practices. The results provide insights into how Becton Dickinson is navigating the current healthcare landscape.

Background

Becton Dickinson & Co., incorporated in New Jersey, operates under the SIC classification of 3841, which pertains to Surgical & Medical Instruments & Apparatus. The company is listed on the New York Stock Exchange under the ticker symbol BDX. As a large accelerated filer, Becton Dickinson has a significant presence in the medical device market, competing with other major players in the industry.

What the Filing Says

The filing reveals that on November 5, 2026, Becton Dickinson announced its financial results for the fourth quarter of its fiscal year, which ended on September 30, 2026. The press release, which is included as Exhibit 99.1, contains financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles (GAAP). The filing states, "The press release furnished as Exhibit 99.1 contains certain financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles (non-GAAP measures)."

Impact

The results reported by Becton Dickinson may affect various stakeholders, including investors, healthcare providers, and competitors within the surgical and medical instruments sector. The company's performance can influence market trends and investor confidence in similar companies.

What's Next

The filing does not specify what happens next for Becton Dickinson, but it is likely that the company will continue to address the challenges and opportunities in the medical device market as it moves forward.

Source: SEC Accession Number 0001628280-26-070511